23 May, 2013Drug Development Costs Keep Obesity Drugs Off the Market


Obesity has been linked to cancer, heart disease, high blood pressure, diabetes, and stroke.  As a common underlying factor in so many preventable…

Read More

16 May, 2013Drug Development Costs for Diabetes Limits Pharmaceutical Players


More than 366 million people are living with diabetes, according to the International Diabetes Federation.  Diabetes has associated health risks, including obesity, blindness,…

Read More